Allegion (NYSE:ALLE) Price Target Raised to $132.00 at UBS Group

Allegion (NYSE:ALLE - Free Report) had its price objective hoisted by UBS Group from $113.00 to $132.00 in a report released on Tuesday morning, Benzinga reports. The firm currently has a neutral rating on the scientific and technical instruments company's stock.

Several other analysts also recently issued reports on the company. Mizuho downgraded Allegion from a buy rating to a neutral rating and increased their price target for the company from $140.00 to $141.00 in a report on Friday, February 23rd. Wells Fargo & Company downgraded Allegion from an overweight rating to an equal weight rating and raised their target price for the company from $139.00 to $140.00 in a report on Wednesday, February 21st. Barclays boosted their target price on shares of Allegion from $121.00 to $122.00 and gave the stock an equal weight rating in a research report on Tuesday, April 2nd. Finally, StockNews.com raised shares of Allegion from a hold rating to a buy rating in a report on Wednesday, April 10th. Six research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of Hold and an average target price of $127.83.

Allegion Trading Down 0.4 %

ALLE stock traded down $0.55 during trading on Tuesday, reaching $126.39. 519,987 shares of the stock traded hands, compared to its average volume of 723,584. The business's 50 day moving average price is $131.05 and its 200-day moving average price is $118.49. The firm has a market capitalization of $11.07 billion, a PE ratio of 20.69, a P/E/G ratio of 4.59 and a beta of 1.14. The company has a debt-to-equity ratio of 1.22, a current ratio of 1.26 and a quick ratio of 0.85. Allegion has a 52-week low of $95.94 and a 52-week high of $136.91.

Allegion (NYSE:ALLE - Get Free Report) last posted its quarterly earnings results on Tuesday, February 20th. The scientific and technical instruments company reported $1.68 EPS for the quarter, beating the consensus estimate of $1.59 by $0.09. Allegion had a net margin of 14.80% and a return on equity of 51.95%. The firm had revenue of $897.40 million for the quarter, compared to analyst estimates of $904.17 million. During the same quarter last year, the firm posted $1.60 earnings per share. Allegion's revenue for the quarter was up 4.2% compared to the same quarter last year. As a group, sell-side analysts forecast that Allegion will post 7.01 earnings per share for the current year.

Allegion Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 28th. Shareholders of record on Friday, June 14th will be paid a dividend of $0.48 per share. The ex-dividend date is Thursday, June 13th. This represents a $1.92 dividend on an annualized basis and a yield of 1.52%. Allegion's dividend payout ratio (DPR) is 31.37%.

Insider Transactions at Allegion

In other news, VP Timothy P. Eckersley sold 5,047 shares of the stock in a transaction dated Monday, March 11th. The shares were sold at an average price of $129.99, for a total transaction of $656,059.53. Following the transaction, the vice president now owns 35,567 shares of the company's stock, valued at $4,623,354.33. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, VP Timothy P. Eckersley sold 5,047 shares of the company's stock in a transaction that occurred on Monday, March 11th. The stock was sold at an average price of $129.99, for a total transaction of $656,059.53. Following the sale, the vice president now directly owns 35,567 shares of the company's stock, valued at approximately $4,623,354.33. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Robert C. Martens sold 5,391 shares of the firm's stock in a transaction on Thursday, February 22nd. The stock was sold at an average price of $132.84, for a total value of $716,140.44. Following the transaction, the senior vice president now owns 7,555 shares in the company, valued at $1,003,606.20. The disclosure for this sale can be found here. Insiders own 0.90% of the company's stock.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the stock. Compass Wealth Management LLC acquired a new stake in shares of Allegion in the 4th quarter worth about $25,000. CVA Family Office LLC bought a new stake in Allegion during the fourth quarter worth approximately $28,000. Robeco Institutional Asset Management B.V. increased its position in shares of Allegion by 19.3% during the 4th quarter. Robeco Institutional Asset Management B.V. now owns 23,634 shares of the scientific and technical instruments company's stock valued at $30,000 after purchasing an additional 3,823 shares during the period. Benjamin Edwards Inc. increased its position in shares of Allegion by 123.1% during the 2nd quarter. Benjamin Edwards Inc. now owns 261 shares of the scientific and technical instruments company's stock valued at $31,000 after purchasing an additional 144 shares during the period. Finally, Ancora Advisors LLC raised its stake in shares of Allegion by 153.3% in the 3rd quarter. Ancora Advisors LLC now owns 380 shares of the scientific and technical instruments company's stock worth $40,000 after buying an additional 230 shares in the last quarter. 92.21% of the stock is currently owned by institutional investors.

Allegion Company Profile

Allegion plc manufactures and sells mechanical and electronic security products and solutions worldwide. The company offers door controls and systems and exit devices; locks, locksets, portable locks, and key systems and services; electronic security products and access control systems; time, attendance, and workforce productivity systems; doors, accessories, and other.